Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat. 2023 Sep; 201(2):257-264.
View in:
PubMed
subject areas
BRCA1 Protein
BRCA2 Protein
Breast Neoplasms
Female
Genes, BRCA1
Humans
Mutation
Raloxifene Hydrochloride
Risk Factors
Tamoxifen
authors with profiles
Olufunmilayo Olopade